Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endocrine Gland Neoplasms × Staining and Labeling × Endocrine × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pheochromocytoma 1 Hyperaldosteronism 1 Endocrine Gland Neoplasms 1 ACTH Syndrome, Ectopic 1

Interventions

selpercatinib 2 repotrectinib 1 pralsetinib 1 lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 Sunitinib 1 Staining and Labeling 1 Lutetium-177 1 Lutetium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05446779 2024-04-16

SuddenDeath

Helsinki University Central Hospital

Active not recruiting

ACTH Syndrome, Ectopic, Endocrine Gland Neoplasms, Hyperaldosteronism, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡